163 related articles for article (PubMed ID: 25304372)
1. Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes.
Sorg S; Pachmann K; Brede-Hekimian K; Freesmeyer M; Winkens T
Cancer Lett; 2015 Jan; 356(2 Pt B):491-5. PubMed ID: 25304372
[TBL] [Abstract][Full Text] [Related]
2. Circulating epithelial cells in patients with thyroid carcinoma. Can they be identified in the blood?
Winkens T; Pachmann K; Freesmeyer M
Nuklearmedizin; 2013; 52(1):7-13. PubMed ID: 23254889
[TBL] [Abstract][Full Text] [Related]
3. Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency.
Espadinha C; Santos JR; Sobrinho LG; Bugalho MJ
Clin Endocrinol (Oxf); 2009 Apr; 70(4):629-35. PubMed ID: 18710471
[TBL] [Abstract][Full Text] [Related]
4. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
[TBL] [Abstract][Full Text] [Related]
5. TSH receptor and thyroid-specific gene expression in human skin.
Cianfarani F; Baldini E; Cavalli A; Marchioni E; Lembo L; Teson M; Persechino S; Zambruno G; Ulisse S; Odorisio T; D'Armiento M
J Invest Dermatol; 2010 Jan; 130(1):93-101. PubMed ID: 19641516
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse.
Barzon L; Boscaro M; Pacenti M; Taccaliti A; Palù G
Int J Cancer; 2004 Jul; 110(6):914-20. PubMed ID: 15170676
[TBL] [Abstract][Full Text] [Related]
7. Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer.
Lin JD; Liou MJ; Hsu HL; Leong KK; Chen YT; Wang YR; Hung WS; Lee HY; Tsai HJ; Tseng CP
Thyroid; 2018 Nov; 28(11):1479-1489. PubMed ID: 30221579
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin, but Not Thyroid-Stimulating Antibodies, Induces Biphasic Regulation of Gene Expression in Human Thyrocytes.
Jang D; Morgan SJ; Klubo-Gwiezdzinska J; Banga JP; Neumann S; Gershengorn MC
Thyroid; 2020 Feb; 30(2):270-276. PubMed ID: 31805824
[No Abstract] [Full Text] [Related]
9. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
[TBL] [Abstract][Full Text] [Related]
10. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
[TBL] [Abstract][Full Text] [Related]
11. Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE.
Fernando R; Lu Y; Atkins SJ; Mester T; Branham K; Smith TJ
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1236-44. PubMed ID: 24708100
[TBL] [Abstract][Full Text] [Related]
12. Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.
Elisei R; Pinchera A; Romei C; Gryczynska M; Pohl V; Maenhaut C; Fugazzola L; Pacini F
J Clin Endocrinol Metab; 1994 Apr; 78(4):867-71. PubMed ID: 8157713
[TBL] [Abstract][Full Text] [Related]
13. BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.
Bastos AU; Oler G; Nozima BH; Moysés RA; Cerutti JM
Eur J Endocrinol; 2015 Oct; 173(4):525-40. PubMed ID: 26338373
[TBL] [Abstract][Full Text] [Related]
14. Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment.
Feng F; Wang H; Fu H; Wu S; Ye Z; Chen S; Li J
Nucl Med Biol; 2011 Oct; 38(7):1053-8. PubMed ID: 21982575
[TBL] [Abstract][Full Text] [Related]
15. Expression of thyroid-related genes in human thymus.
Spitzweg C; Joba W; Heufelder AE
Thyroid; 1999 Feb; 9(2):133-41. PubMed ID: 10090312
[TBL] [Abstract][Full Text] [Related]
16. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.
Vendittelli F; Raffaelli M; Fadda G; Carelli-Alinovi C; Paolillo C; Bellantone R; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2012 Jan; 50(4):715-20. PubMed ID: 22505562
[TBL] [Abstract][Full Text] [Related]
17. Iodination of proteins in TPO transfected thyroid cancer cells is independent of NIS.
Wenzel A; Upadhyay G; Schmitt TL; Loos U
Mol Cell Endocrinol; 2003 Dec; 213(1):99-108. PubMed ID: 15062578
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma.
Lin HC; Liou MJ; Hsu HL; Hsieh JC; Chen YA; Tseng CP; Lin JD
Oncotarget; 2016 Mar; 7(13):17242-53. PubMed ID: 26684026
[TBL] [Abstract][Full Text] [Related]
20. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.
Mu D; Huang R; Li S; Ma X; Lou C; Kuang A
Cancer Gene Ther; 2012 Jun; 19(6):402-11. PubMed ID: 22498723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]